| 睑板腺功能障碍研究进展 |
| |
| 引用本文： | 孟珠,赵少贞.睑板腺功能障碍研究进展[J].国际眼科纵览,2016(6):426-431. |
| |
| 作者姓名： | 孟珠 赵少贞 |
| |
| 作者单位： | 300384,天津医科大学眼科医院 天津医科大学眼视光学院 天津医科大学眼科研究所 |
| |
| 基金项目： | Key Projects of Science and Technology Support Program of Tianjin Municipal Science and Technology Commission(13ZCZDSY00900)天津市科委科技支撑计划重点项目(13ZCZDSY00900) |
| |
| 摘 要： | 睑板腺功能障碍(meibomian gland dysfunction,MGD)以睑板腺终末导管阻塞和睑板腺分泌物的质量或数量改变为特征.睑板腺分泌的脂质成分发生相应改变,造成泪膜的稳定性下降和泪液蒸发量增加,从而导致干眼发生.目前MGD的发病原因尚不明确,临床上采取的治疗往往是对症治疗.本文主要对MGD的泪膜脂质变化及其国内外诊治进展进行总结.
|
| 关 键 词： | 睑板腺功能障碍 泪膜 脂质层 |
Research progress meibomian gland dysfunction |
| |
| Abstract: | Meibomian gland dysfunction (MGD) is a common ocular surface disease,characterized by terminal duct obstruction and (or) quality or quantity changes in the glandular secretion.The corresponding change of lipid composition results in the decline of tear flim stability and the increase of tear evaporation,which leads to dry eye.At this point,the causes of MGD remain unknown.Symptomatic therapy is commonly used clinical thrapeutic measures.In this article we mainly summarized the change of lipid and the development of diagnosis and treatment of MGD at home and abroad. |
| |
| Keywords: | Meibomian gland dysfunction tear film lipid layer |
| 本文献已被 万方数据 等数据库收录！ |
